Recent studies have reported that plasma proinflammatory biomarkers, such as soluble TNF receptors 1 and 2 (TNFR-1 and TNFR2) were associated with the increased risk of progression of diabetic kidney disease, even after adjustment for established clinical risk factors (32, 33). This evidence concerns the gene TNFRSF1B and diabetic kidney disease.